HOME >> BIOLOGY >> NEWS
Top biomedical researchers form Editorial Directorate for open-access publishing venture

Some of the world's leading biological and medical scientists have joined the Editorial Directorate of BioMed Central, a new publishing house that will give free on-line access to biomedical research. BioMed Central will allow researchers around the world to access peer-reviewed research articles free-of-charge, and without the traditional barriers to access imposed by conventional publishers. The BioMed Central Directorate includes:

PROFESSOR ELIZABETH H. BLACKBURN
Professor of Biochemistry and Biophysics and Professor of Microbiology and Immunology at the University of California, San Francisco (USA)

DR STEVEN E. HYMAN
Director of the National Institute of Mental Health (USA)

PROFESSOR MARC W. KIRSCHNER
Head of the Department of Cell Biology at Harvard Medical School. (USA)

PROFESSOR PHILIPPE KOURILSKY
Professor of the Collège de France and Director General of the Pasteur Institute (France)

PROFESSOR JOSEPH BOYD MARTIN
Dean of the Faculty of Medicine at Harvard Medical School (USA)

DR DAVID G. NATHAN
President of the Dana-Farber Cancer Institute (USA)

DR PAUL NURSE
Director-General of the Imperial Cancer Research Fund (UK).

DR HAROLD E. VARMUS
President of the Memorial Sloan-Kettering Cancer Center (USA)

PROFESSOR SIR DAVID WEATHERALL
Regius Professor of Medicine at the University of Oxford (UK)

PROFESSOR MITSUHIRO YANAGIDA
Professor of Kyoto University, Graduate School of Biostudies (Japan)

"BioMed Central will be the most significant development for disseminating the results of biomedical research in our lifetime", says Dr Paul Nurse.

"BioMed Central and other on-line initiatives will serve to make science more democratic, and more efficient, and in so doing will speed scientific progress," says Dr Steven Hyman. "In the long run, I think that journals that are not freely available in electronic formats will be read less and less".

"BioMed Central promises to d
'"/>

Contact: Andrew McLaughlin
andrew@biomedcentral.com
44-20-7323-0323
BioMed Central
21-May-2000


Page: 1 2 3

Related biology news :

1. Illustrated guidebook published for Chinese biomedical scientists and students
2. NIH roadmap for biomedical research focus of chemists at American Chemical Society meeting
3. Ottawas leadership in biomedical and health research has paid off
4. New world record magnet for chemical and biomedical research
5. Telescience recognized for facilitating biomedical research on a global network
6. Digital Biology Week: Building a national infrastructure for biomedical computing
7. New grants enable biomedical research centers to share science with their communities
8. Dr. Robert Langer, distinguished leader in the field of biomedical engineering, to lecture at NIH
9. UW-Madison scientists return to rat as biomedical research tool
10. Stanford biomedical ethicist speaks on role of race in scientific research
11. University of New Hampshire launches biomedical research network with $5.6 million grant

Post Your Comments:
(Date:8/25/2015)... BELLEVUE, Wash. , Aug. 25, 2015 ... systems, announced today it will unveil its "Guardian S" ... at the National Tactical Officers Association Conference on August ... Guardian S is the first-ever commercially available energetically autonomous ... research and in-field trials and is protected by more ...
(Date:8/20/2015)... , Aug. 20, 2015 The wearable ... that are active and healthy. However, wearable technology ... hospital environment to help improve diagnostic capabilities and ... from the Wearable Technologies Conference 2015 , ... applications for wearables in healthcare.    ...
(Date:8/19/2015)... 19, 2015  VOXX International Corporation (Nasdaq: ... into a Definitive Agreement to purchase the assets, ... market leader EyeLock through an acquiring entity.  Upon ... controlling interest in the acquiring entity. The closing ... due diligence.  Expanding on its existing supply chain ...
Breaking Biology News(10 mins):Sarcos to Debut First-of-its-Kind Snake Robot 2Sarcos to Debut First-of-its-Kind Snake Robot 3Leaf Healthcare Releases Video from Wearable Technology Conference on New Applications for Wearables in the Hospital Environment 2Leaf Healthcare Releases Video from Wearable Technology Conference on New Applications for Wearables in the Hospital Environment 3VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 2VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 3VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 4VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 5
(Date:8/26/2015)... 2015  Platform therapeutic company Symic Biomedical, Inc. ... $1.5M Phase II SBIR grant from the National ... therapeutic agent to reduce arteriovenous fistula (AVF) failures, ... renal disease (ESRD) patients undergoing hemodialysis. The two-year ... and Digestive and Kidney Diseases (NIDDK), will allow ...
(Date:8/26/2015)... HONG KONG , Aug. 26, 2015 ... "Company"), China,s leading provider of ... and stem cell storage services, today announced that the ... Holdings Limited ("MO2"), an entity wholly owned by Mr. ... the Company, has acquired the outstanding shares (the "Shares") ...
(Date:8/26/2015)... ... August 26, 2015 , ... PRC Clinical, ... new business relationships with local sponsors in southern California. The Clinical Trial Management Expert ... development processes and regulatory pathways., , Stem Cell Meeting ...
(Date:8/25/2015)... ... August 25, 2015 , ... A new optical ... is described by University of Illinois researchers in the Journal of Biomedical ... In “ Breast cancer diagnosis using spatial light interference microscopy ,” published 20 ...
Breaking Biology Technology:Symic Biomedical Awarded $1.5MM NIH Phase II SBIR Grant to Develop its Proteoglycan Mimetic Therapeutics to Reduce Vascular Access Failures in ESRD 2Symic Biomedical Awarded $1.5MM NIH Phase II SBIR Grant to Develop its Proteoglycan Mimetic Therapeutics to Reduce Vascular Access Failures in ESRD 3China Cord Blood Corporation Receives Notice of Transactions Regarding its 7% Senior Convertible Notes Due 2017 2China Cord Blood Corporation Receives Notice of Transactions Regarding its 7% Senior Convertible Notes Due 2017 3PRC Clinical To Attend Major Industry Conferences And Meet Sponsor Companies In The San Diego Biotech Hub 2PRC Clinical To Attend Major Industry Conferences And Meet Sponsor Companies In The San Diego Biotech Hub 3New Optical Method Promises Faster, More Accurate Diagnosis of Breast Cancer 2New Optical Method Promises Faster, More Accurate Diagnosis of Breast Cancer 3New Optical Method Promises Faster, More Accurate Diagnosis of Breast Cancer 4
Cached News: